Sugar-based nanoparticles for respiratory diseases: a new paradigm in the nanoworld-Reference-Cited by-同舟云学术

Sugar-based nanoparticles for respiratory diseases: a new paradigm in the nanoworld

Published:2020-11 Issue:21 Volume:12 Page:1887-1890
ISSN:1756-8919
Container-title:Future Medicinal Chemistry
language:en
Short-container-title:Future Medicinal Chemistry

Author:

Chan Yinghan¹^ORCID,Ng Sin Wi¹^ORCID,Mehta Meenu²^ORCID,Gupta Gaurav³^ORCID,Chellappan Dinesh Kumar⁴^ORCID,Dua Kamal²⁵⁶^ORCID

Affiliation:

1. School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia

2. Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia

3. School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India

4. Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia

5. Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, NSW 2305, Australia

6. School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India

Publisher

Future Science Ltd

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.future-science.com/doi/pdf/10.4155/fmc-2020-0206

Reference20 articles.

1. Identification of biomarkers and genetic approaches toward chronic obstructive pulmonary disease

2. Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases

3. Designing polymers with sugar-based advantages for bioactive delivery applications

4. Polyacrylamide and related polymers

5. Glycopolymer-based nanoparticles: synthesis and application

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Toll-Like Receptors for the Treatment of Lung Cancer;Immunotherapy Against Lung Cancer;2024

2. Beyond the genome: lncRNAs as regulators of the PI3K/AKT pathway in lung cancer;Pathology - Research and Practice;2023-11

3. Advanced nanomedicine-based therapeutics for targeting airway inflammatory diseases;Recent Developments in Anti-Inflammatory Therapy;2023

4. Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis;Journal of Drug Delivery Science and Technology;2022-09

5. Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective;Life Sciences;2021-09